Sign In

Vikram Chand

Vikram Chand, MD is a Vice President and Global Franchise Head at AstraZeneca, based in Newtown, Connecticut.1 He is a medical oncologist and hematologist by training with over 15 years of experience in the biopharmaceutical industry.1 In his current role, Dr. Chand leads the mid-late phase clinical strategy and development of an antibody-drug conjugate asset across multiple solid tumors.1

Dr. Chand's career highlights include:

  • Joined AstraZeneca in March 2018 as Vice President, Global Development Lead for Immuno-Oncology in Lung Cancer1
  • Progressed to Vice President, Global Clinical Head for Immuno-Oncology in Thoracic Malignancies in March 20201
  • Became Vice President, Global Product Leader for Datopotamab Deruxtecan in August 20201
  • Currently serves as Vice President, Global Franchise Head for Datopotamab Deruxtecan since September 20221

Prior to AstraZeneca, Dr. Chand held leadership positions at EMD Serono and Boehringer Ingelheim Pharmaceuticals.1 He has also worked as a practicing hematologist/oncologist at US Oncology and Gundersen Lutheran.1

Dr. Chand received his medical degree (MBBS) from Delhi University's Maulana Azad Medical College.12 He completed his residency in Internal Medicine at Gundersen Medical Foundation and a fellowship in Hematology, Oncology, Blood and Bone Marrow Transplantation at the University of Iowa.1

Related Questions

What are Vikram Chand's main responsibilities at AstraZeneca?
How has Vikram Chand's career evolved over the years?
What specific projects has Vikram Chand led at AstraZeneca?
What is Vikram Chand's educational background?
How has Vikram Chand contributed to the field of oncology?
Vikram Chand
Vikram Chand, photo 1
Vikram Chand, photo 2
Add to my network